BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29769992)

  • 1. Advancing surveillance of antimicrobial resistance: Summary of the 2015 CIDSC Report.
    Amaratunga K; Tarasuk J; Tsegaye L; Archibald CP; ;
    Can Commun Dis Rep; 2016 Nov; 42(11):232-237. PubMed ID: 29769992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial use and antimicrobial resistance trends in Canada: 2014.
    Ebrahim M; Gravel D; Thabet C; Abdesselam K; Paramalingam S; Hyson C
    Can Commun Dis Rep; 2016 Nov; 42(11):227-231. PubMed ID: 29769991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial resistance among GLASS priority pathogens from Pakistan: 2006-2018.
    Saeed DK; Farooqi J; Shakoor S; Hasan R
    BMC Infect Dis; 2021 Dec; 21(1):1231. PubMed ID: 34876041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020.
    Fu P; Xu H; Jing C; Deng J; Wang H; Hua C; Chen Y; Chen X; Zhang T; Zhang H; Chen Y; Yang J; Lin A; Wang S; Cao Q; Wang X; Deng H; Cao S; Hao J; Gao W; Huang Y; Yu H; Wang C
    Microbiol Spectr; 2021 Dec; 9(3):e0028321. PubMed ID: 34730410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of the World Health Organization Global Antimicrobial Resistance Surveillance System in Uganda, 2015-2020: Mixed-Methods Study Using National Surveillance Data.
    Nabadda S; Kakooza F; Kiggundu R; Walwema R; Bazira J; Mayito J; Mugerwa I; Sekamatte M; Kambugu A; Lamorde M; Kajumbula H; Mwebasa H
    JMIR Public Health Surveill; 2021 Oct; 7(10):e29954. PubMed ID: 34673531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2014-2018.
    Surveillance CNI
    Can Commun Dis Rep; 2020 May; 46(5):99-112. PubMed ID: 32558807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global geographic trends in antimicrobial resistance: the role of international travel.
    Frost I; Van Boeckel TP; Pires J; Craig J; Laxminarayan R
    J Travel Med; 2019 Dec; 26(8):. PubMed ID: 31115466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The challenges and successes of implementing a sustainable antimicrobial resistance surveillance programme in Nepal.
    Malla S; Dumre SP; Shakya G; Kansakar P; Rai B; Hossain A; Nair GB; Albert MJ; Sack D; Baker S; Rahman M;
    BMC Public Health; 2014 Mar; 14():269. PubMed ID: 24650008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicountry Distribution and Characterization of Extended-spectrum β-Lactamase-associated Gram-negative Bacteria From Bloodstream Infections in Sub-Saharan Africa.
    Toy T; Pak GD; Duc TP; Campbell JI; El Tayeb MA; Von Kalckreuth V; Im J; Panzner U; Cruz Espinoza LM; Eibach D; Dekker DM; Park SE; Jeon HJ; Konings F; Mogeni OD; Cosmas L; Bjerregaard-Andersen M; Gasmelseed N; Hertz JT; Jaeger A; Krumkamp R; Ley B; Thriemer K; Kabore LP; Niang A; Raminosoa TM; Sampo E; Sarpong N; Soura A; Owusu-Dabo E; Teferi M; Yeshitela B; Poppert S; May J; Kim JH; Chon Y; Park JK; Aseffa A; Breiman RF; Schütt-Gerowitt H; Aaby P; Adu-Sarkodie Y; Crump JA; Rakotozandrindrainy R; Meyer CG; Sow AG; Clemens JD; Wierzba TF; Baker S; Marks F
    Clin Infect Dis; 2019 Oct; 69(Suppl 6):S449-S458. PubMed ID: 31665776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019-June 2021).
    Kariyawasam RM; Julien DA; Jelinski DC; Larose SL; Rennert-May E; Conly JM; Dingle TC; Chen JZ; Tyrrell GJ; Ronksley PE; Barkema HW
    Antimicrob Resist Infect Control; 2022 Mar; 11(1):45. PubMed ID: 35255988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of gut microbiota and probiotic organisms on the properties of extended spectrum beta-lactamase producing and carbapenem resistant Enterobacteriaceae including growth, beta-lactamase activity and gene transmissibility.
    Kunishima H; Ishibashi N; Wada K; Oka K; Takahashi M; Yamasaki Y; Aoyagi T; Takemura H; Kitagawa M; Kaku M
    J Infect Chemother; 2019 Nov; 25(11):894-900. PubMed ID: 31178280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An assessment of antimicrobial resistant disease threats in Canada.
    Garner MJ; Carson C; Lingohr EJ; Fazil A; Edge VL; Trumble Waddell J
    PLoS One; 2015; 10(4):e0125155. PubMed ID: 25905797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
    Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
    MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2016-2020.
    Canadian Nosocomial Infection Surveillance Program1*
    Can Commun Dis Rep; 2022 Jul; 48(7-8):308-324. PubMed ID: 38093808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance and comparison of antimicrobial susceptibility patterns of ESKAPE organisms isolated from patients with bacteraemia in South Africa, 2016 - 2017.
    Ismail H; Lowman W; Govind CN; Swe Swe-Han K; Maloba MRB; Bamford C; Perovic O
    S Afr Med J; 2019 Nov; 109(12):934-940. PubMed ID: 31865955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
    Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
    MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern -A hospital based cross sectional study.
    Fernando MM; Luke WA; Miththinda JK; Wickramasinghe RD; Sebastiampillai BS; Gunathilake MP; Silva FH; Premaratna R
    BMC Infect Dis; 2017 Feb; 17(1):138. PubMed ID: 28187754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of the 1997 SENTRY Antimicrobial Surveillance Program in Three Brazilian Medical Centers.
    Sader HS; Sampaio JL; Zoccoli C; Jones RN
    Braz J Infect Dis; 1999 Apr; 3(2):63-79. PubMed ID: 11098193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major Bloodstream Infection-Causing Bacterial Pathogens and Their Antimicrobial Resistance in South Korea, 2017-2019: Phase I Report From Kor-GLASS.
    Kim D; Yoon EJ; Hong JS; Choi MH; Kim HS; Kim YR; Kim YA; Uh Y; Shin KS; Shin JH; Park JS; Park KU; Won EJ; Kim SH; Shin JH; Kim JW; Lee S; Jeong SH
    Front Microbiol; 2021; 12():799084. PubMed ID: 35069503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization as a tool to combat antimicrobial resistance.
    Spika J; Rud EW
    Can Commun Dis Rep; 2015 Nov; 41(Suppl 5):7-10. PubMed ID: 29769969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.